216 related articles for article (PubMed ID: 30127630)
1. Impact of concomitant nontuberculous mycobacteria and
Hsieh MH; Lin CY; Wang CY; Fang YF; Lo YL; Lin SM; Lin HC
Infect Drug Resist; 2018; 11():1137-1143. PubMed ID: 30127630
[TBL] [Abstract][Full Text] [Related]
2. Impacts of Nontuberculous Mycobacteria Isolates in Non-cystic Fibrosis Bronchiectasis: A 16-Year Cohort Study in Taiwan.
Lin CY; Huang HY; Hsieh MH; Fang YF; Lo YL; Lin SM; Huang YT; Yeh CH; Wang CH; Lin HC
Front Microbiol; 2022; 13():868435. PubMed ID: 35509319
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and factors associated with nontuberculous mycobacteria in non-cystic fibrosis bronchiectasis: a multicenter observational study.
Máiz L; Girón R; Olveira C; Vendrell M; Nieto R; Martínez-García MA
BMC Infect Dis; 2016 Aug; 16(1):437. PubMed ID: 27549788
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis.
Martiniano SL; Sontag MK; Daley CL; Nick JA; Sagel SD
Ann Am Thorac Soc; 2014 Jan; 11(1):36-44. PubMed ID: 24251858
[TBL] [Abstract][Full Text] [Related]
5. Sputum Proteomics in Nontuberculous Mycobacterial Lung Disease.
Hull RC; Huang JTJ; Barton AK; Keir HR; Ellis H; Cookson WOC; Moffatt MF; Loebinger MR; Chalmers JD
Chest; 2022 May; 161(5):1180-1191. PubMed ID: 34838525
[TBL] [Abstract][Full Text] [Related]
6. Nontuberculous mycobacteria in diffuse panbronchiolitis.
Tsuji T; Tanaka E; Yasuda I; Nakatsuka Y; Kaji Y; Yasuda T; Hashimoto S; Hwang MH; Hajiro T; Taguchi Y
Respirology; 2015 Jan; 20(1):80-6. PubMed ID: 25269823
[TBL] [Abstract][Full Text] [Related]
7. Non-tuberculous mycobacteria in patients with bronchiectasis.
Wickremasinghe M; Ozerovitch LJ; Davies G; Wodehouse T; Chadwick MV; Abdallah S; Shah P; Wilson R
Thorax; 2005 Dec; 60(12):1045-51. PubMed ID: 16227333
[TBL] [Abstract][Full Text] [Related]
8. Nontuberculous mycobacteria in bronchiectasis: Prevalence and patient characteristics.
Fowler SJ; French J; Screaton NJ; Foweraker J; Condliffe A; Haworth CS; Exley AR; Bilton D
Eur Respir J; 2006 Dec; 28(6):1204-10. PubMed ID: 16807259
[TBL] [Abstract][Full Text] [Related]
9. Screening practices for nontuberculous mycobacteria at US cystic fibrosis centers.
Low D; Wilson DA; Flume PA
J Cyst Fibros; 2020 Jul; 19(4):569-574. PubMed ID: 32178969
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and Clinical Implications of Nontuberculous Mycobacteria Isolation and Infection among Patients with Bronchiectasis in the Jerusalem Area.
Kuint R; Azmanov H; Shalom A; Berkman N
Isr Med Assoc J; 2024 Mar; 26(3):180-185. PubMed ID: 38493330
[TBL] [Abstract][Full Text] [Related]
11. Five-Year Outcomes Among U.S. Bronchiectasis and Nontuberculous Mycobacterial Registry Patients.
Aksamit TR; Locantore N; Addrizzo-Harris D; Ali J; Barker A; Basavaraj A; Behrman M; Brunton AE; Chalmers S; Choate R; Dean NC; DiMango A; Fraulino D; Johnson MM; Lapinel NC; Maselli DJ; McShane PJ; Metersky ML; Miller BE; Naureckas ET; O'Donnell AE; Olivier KN; Prusinowski E; Restrepo MI; Richards CJ; Rhyne G; Schmid A; Solomon GM; Tal-Singer R; Thomashow B; Tino G; Tsui K; Varghese SA; Warren HE; Winthrop K; Zha BS
Am J Respir Crit Care Med; 2024 Apr; ():. PubMed ID: 38668710
[TBL] [Abstract][Full Text] [Related]
12. Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis.
Mirsaeidi M; Hadid W; Ericsoussi B; Rodgers D; Sadikot RT
Int J Infect Dis; 2013 Nov; 17(11):e1000-4. PubMed ID: 23683809
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of methods for the isolation of nontuberculous mycobacteria from patients with cystic fibrosis, bronchiectasis and patients assessed for lung transplantation.
Stephenson D; Perry A; Appleby MR; Lee D; Davison J; Johnston A; Jones AL; Nelson A; Bourke SJ; Thomas MF; De Soyza A; Lordan JL; Lumb J; Robb AE; Samuel JR; Walton KE; Perry JD
BMC Pulm Med; 2019 Jan; 19(1):19. PubMed ID: 30665395
[TBL] [Abstract][Full Text] [Related]
14. Nontuberculous mycobacteria in cystic fibrosis and non-cystic fibrosis bronchiectasis.
Park IK; Olivier KN
Semin Respir Crit Care Med; 2015 Apr; 36(2):217-24. PubMed ID: 25826589
[TBL] [Abstract][Full Text] [Related]
15. Assessing effects of inhaled antibiotics in adults with non-cystic fibrosis bronchiectasis--experiences from recent clinical trials.
Paredes Aller S; Quittner AL; Salathe MA; Schmid A
Expert Rev Respir Med; 2018 Sep; 12(9):769-782. PubMed ID: 30025482
[TBL] [Abstract][Full Text] [Related]
16. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis.
Olivier KN; Weber DJ; Wallace RJ; Faiz AR; Lee JH; Zhang Y; Brown-Elliot BA; Handler A; Wilson RW; Schechter MS; Edwards LJ; Chakraborti S; Knowles MR;
Am J Respir Crit Care Med; 2003 Mar; 167(6):828-34. PubMed ID: 12433668
[TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients.
Ryall B; Davies JC; Wilson R; Shoemark A; Williams HD
Eur Respir J; 2008 Sep; 32(3):740-7. PubMed ID: 18480102
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of pulmonary artery dilation in non-cystic fibrosis bronchiectasis: a computed tomography analysis from a cohort of the US Bronchiectasis and Nontuberculous Mycobacteria Research Registry.
Karamooz E; Brixey AG; Rydzak CE; Primack SL; Markwardt S; Barker AF
J Thorac Dis; 2024 Feb; 16(2):1496-1502. PubMed ID: 38505050
[TBL] [Abstract][Full Text] [Related]
19. Clinical course and significance of nontuberculous mycobacteria and its subtypes in cystic fibrosis.
Eikani MS; Nugent M; Poursina A; Simpson P; Levy H
BMC Infect Dis; 2018 Jul; 18(1):311. PubMed ID: 29980189
[TBL] [Abstract][Full Text] [Related]
20. Household proximity to water and nontuberculous mycobacteria in children with cystic fibrosis.
Bouso JM; Burns JJ; Amin R; Livingston FR; Elidemir O
Pediatr Pulmonol; 2017 Mar; 52(3):324-330. PubMed ID: 28135043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
